For its second fiscal quarter (ending June 30), MacroGenics Inc (NASDAQ: MGNX) has reported a -196% decline in E.P.S. from $0.93 a year ago to $-0.89 in the current quarter. This performance was $-0.30 short […]
Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported a loss for its second fiscal quarter (ending June 30) of $-2.88 versus $0.13 for the same period a year ago — a decline of -2315%. This result […]
Jacobs Solutions Inc (NYSE: J) has reported E.P.S. of $1.17 for its third fiscal quarter (ending June 30) versus $1.29 for the same period a year ago — a decline of -9%. This performance was […]
Inogen Inc (NASDAQ: INGN) has reported a loss for its second fiscal quarter (ending June 30) of $-0.24 versus a loss $-0.42 for the same period a year ago. This result exceeded the consensus estimate […]
For its second fiscal quarter (ending June 30), Ingredion Inc (NYSE: INGR) has reported a -9% decline in E.P.S. from $2.46 a year ago to $2.25 in the current quarter. This performance was $-0.24 short […]
HUTCHMED (China) Limited (NASDAQ: HCM) stock closed at $20.22 on 8/6/24 after a major increase of 10.9%. Moreover, above average trading volume at 127% of normal accompanied the advance. The stock has risen 10.6% during […]
Green Plains Inc (NASDAQ: GPRE) has reported E.P.S. of $-0.38 for its second fiscal quarter (ending June 30) versus $-0.89 for the same period a year ago. This performance was $-0.17 short of the consensus […]
For its second fiscal quarter (ending June 30), Globus Medical Inc (NYSE: GMED) has reported a -60% decline in E.P.S. from $0.57 a year ago to $0.23 in the current quarter. This performance was $-0.45 […]
Flotek Industries Inc (NYSE: FTK) has reported E.P.S. of $0.07 for its second fiscal quarter (ending June 30) versus $0.00 for the same period a year ago. For the latest four quarters through June 30, […]
For its second fiscal quarter (ending June 30), Exelixis Inc (NASDAQ: EXEL) has reported a 212% increase in E.P.S. from $0.25 a year ago to $0.78 in the current quarter. This performance was $0.41 better […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research